ArticleNPJ breast cancer2026
Prevalence of HER2-low status and outcomes in early-stage HER2-negative breast cancer.
Akshara Singareeka Raghavendra et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it